Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Smart Eye in connection with a capital procurement of MSEK 275
Mandate

Vinge has advised Smart Eye in connection with a capital procurement of MSEK 275

May 26, 2021 Capital Markets and Public M&A

Vinge has advised Smart Eye Aktiebolag (publ) in connection with a directed new share issue of MSEK 275. The subscription price, which is equivalent to the closing price of the shares on First North Growth Market, was determined via a so-called accelerated book building procedure led by Carnegie.

Vinge’s team consisted of Anders Strid, Edin Agic and Hampus Olsson.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026

Vinge has advised Resurs in connection with its strategic partnership with Kustom

 Vinge has advised Resurs in connection with its strategic partnership with Kustom (formerly Klarna Checkout), a fast-growing player in the digital commerce sector. The partnership enables Resurs to accelerate its strategic development by offering a check-out solution to its merchants, built on Kustom’s market-leading infrastructure.
March 25, 2026